Acorda Therapeutics Inc (NASDAQ:ACOR)

23.35
Delayed Data
As of Apr 20
 -0.05 / -0.21%
Today’s Change
13.60
Today|||52-Week Range
29.60
+8.86%
Year-to-Date
New Strong Sell Stocks for April 18th
Apr 18 / Zacks.com - Paid Partner Content
 

Today’s Trading

Previous close23.40
Today’s open23.30
Day’s range22.69 - 23.50
Volume205,566
Average volume (3 months)600,381
Market cap$1.2B
Data as of 4:00pm ET, 04/20/2018

Growth & Valuation

Earnings growth (last year)-539.47%
Earnings growth (this year)-90.06%
Earnings growth (next 5 years)+29.00%
Revenue growth (last year)+13.22%
P/E ratioNM
Price/Sales1.68
Price/Book2.29

Competitors

 Today’s
change
Today’s
% change
HRTXHeron Therapeutics I...+1.30+4.36%
ZIOPZIOPHARM Oncology In...+0.03+0.70%
ATNXAthenex Inc-0.33-1.98%
BYSIBeyondspring Inc+3.60+13.09%
Data as of 4:00pm ET, 04/20/2018

Financials

Next reporting dateMay 2, 2018
EPS forecast (this quarter)$0.67
Annual revenue (last year)$588.3M
Annual profit (last year)-$223.4M
Net profit margin-37.97%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
Ronald Cohen
Chief Scientific Officer
Andrew R. Blight
Corporate headquarters
Ardsley, New York

Forecasts